[HTML][HTML] Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
…, A Lovato, C De Filippis, F Coppee, N Fakhry… - European Archives of …, 2020 - Springer
Objective To investigate the occurrence of olfactory and gustatory dysfunctions in patients
with laboratory-confirmed COVID-19 infection. Methods Patients with laboratory-confirmed …
with laboratory-confirmed COVID-19 infection. Methods Patients with laboratory-confirmed …
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
…, G Cammaroto, N Fakhry… - Journal of internal …, 2020 - Wiley Online Library
Background The clinical presentation of European patients with mild‐to‐moderate COVID‐19
infection is still unknown. Objective To study the clinical presentation of COVID‐19 in …
infection is still unknown. Objective To study the clinical presentation of COVID‐19 in …
Equivalence randomized trial to compare treatment on the basis of sentinel node biopsy versus neck node dissection in operable T1-T2N0 oral and oropharyngeal …
…, G Poissonnet, A Moyà Plana, N Fakhry… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Sentinel node (SN) biopsy is accurate in operable oral and oropharyngeal cT1-T2N0
cancer (OC), but, to our knowledge, the oncologic equivalence of SN biopsy and neck …
cancer (OC), but, to our knowledge, the oncologic equivalence of SN biopsy and neck …
Features of mild-to-moderate COVID-19 patients with dysphonia
…, F El Afia, MR Barillari, G Cammaroto, N Fakhry… - Journal of Voice, 2022 - Elsevier
Introduction To explore the prevalence of dysphonia in European patients with mild-to-moderate
COVID-19 and the clinical features of dysphonic patients. Methods The clinical and …
COVID-19 and the clinical features of dysphonic patients. Methods The clinical and …
Systematic review of international guidelines for tracheostomy in COVID-19 patients
…, JR Lechien, C Calvo-Henriquez, N Fakhry… - Oral Oncology, 2020 - Elsevier
At this moment, the world lives under the SARS-CoV-2 outbreak pandemic. As Otolaryngologists
- Head & Neck Surgeons, we need to perform and participate in examinations and …
- Head & Neck Surgeons, we need to perform and participate in examinations and …
Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic …
…, S Gabriel, E Beschmout, I Morange, N Fakhry… - European journal of …, 2016 - Springer
Purpose Pheochromocytomas/paragangliomas (PHEOs/PGLs) overexpress somatostatin
receptors and recent studies have already shown excellent results in the localization of these …
receptors and recent studies have already shown excellent results in the localization of these …
18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?
…, I Morange, P Niccoli-Sire, N Fakhry… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Our objective was to evaluate 18 F-FDG PET uptake in patients with nonmetastatic and
metastatic chromaffin-derived tumors. Methods: Twenty-eight consecutive unrelated patients with …
metastatic chromaffin-derived tumors. Methods: Twenty-eight consecutive unrelated patients with …
[PDF][PDF] Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
…, N Gourdin, R Remark, E Lechevallier, N Fakhry… - Cell Reports …, 2022 - cell.com
Harnessing innate immunity is emerging as a promising therapeutic approach in cancer.
We report here the design of tetraspecific molecules engaging natural killer (NK) cell-activating …
We report here the design of tetraspecific molecules engaging natural killer (NK) cell-activating …
[HTML][HTML] A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors
S Atallah, O Casiraghi, N Fakhry, M Wassef… - European journal of …, 2020 - Elsevier
Background Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head and neck
tumours [1] and 10% of salivary glands malignant tumours. The main objective of our study is …
tumours [1] and 10% of salivary glands malignant tumours. The main objective of our study is …
Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant
J Di Cristofaro, M Marcy, V Vasko, F Sebag, N Fakhry… - Human pathology, 2006 - Elsevier
Although the follicular variant of papillary thyroid carcinoma (FVPTC) has been classified as
a papillary cancer based on nuclear features, its follicular growth pattern and potential for …
a papillary cancer based on nuclear features, its follicular growth pattern and potential for …